Long-term Efficacy of Pramipexole in Anhedonic Depression

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

NCT06094907 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression

NCT04936126 ·Status: UNKNOWN ·Phase: PHASE4

Escitalopram in Adult Patients With Major Depressive Disorder

NCT00668525 ·Status: COMPLETED ·Phase: PHASE3

Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole

NCT01066897 ·Status: TERMINATED ·Phase: PHASE4

A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure

NCT06635135 ·Status: TERMINATED ·Phase: PHASE3

The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD

NCT00163059 ·Status: COMPLETED ·Phase: PHASE2

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 ·Status: COMPLETED ·Phase: PHASE2

Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

NCT00514865 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT04985942 ·Status: COMPLETED ·Phase: PHASE3

ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)

NCT07253324 ·Status: COMPLETED ·Phase: PHASE1

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

NCT00759395 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects

NCT05320107 ·Status: RECRUITING ·Phase: PHASE1

Lexapro and Pramipexole and to Treat Major Depression

NCT00086307 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Depression in the Elderly

NCT00130455 ·Status: TERMINATED ·Phase: PHASE4

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT05061706 ·Status: COMPLETED ·Phase: PHASE3

Study of Naltrexone-Induced Blockade of Antidepressant Effects

NCT04322526 ·Status: COMPLETED ·Phase: PHASE4

Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder

NCT05952713 ·Status: COMPLETED

An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

NCT04433858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

NCT05455684 ·Status: COMPLETED ·Phase: PHASE3

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

NCT00761306 ·Status: COMPLETED ·Phase: PHASE2

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects

NCT07022405 ·Status: RECRUITING ·Phase: PHASE2

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

NCT05850689 ·Status: RECRUITING ·Phase: PHASE3

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

NCT05537584 ·Status: COMPLETED ·Phase: PHASE4

Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

NCT00949767 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study

NCT01152996 ·Status: COMPLETED ·Phase: PHASE3